medline.ch Gastroenterologie Leber Leberzirrhose

	A Multicenter Phase II Study on Atezolizumab plus Bevacizumab Combination Therapy in Patients with Unresectable Hepatocellular Carcinoma and Child-Pugh Classification B Cirrhosis: CHALLENGE Trial. Liver Cancer Terashima T, Ikeda M, Yamashita T, Okusaka T, Imaoka H, Kawaoka T, Kobayashi S, Ogasawara S, Hiraoka A, Nakano M, Okano N, Sugimoto R, Moriguchi M, Inaba Y, Shinoda S, Ueno M, Kudo M, Furuse J, Nagano H. PMID: 42158105 [PubMed - as supplied by publisher]
	Trends in mortality from liver cancer with hepatic fibrosis/cirrhosis in the United States, 1999-2020: a retrospective population-based study. BMC Gastroenterol Peng S, Zhao X, Wang X, Ding H, Nie Y, Qi J, Zhu Q. PMID: 42157090 [PubMed - as supplied by publisher]
	Delisting for clinical improvement as a proxy for recompensated cirrhosis on the U.S. liver transplant waitlist: A retrospective cohort study. Liver Transpl Khan S, Aby ES. PMID: 42155105 [PubMed - as supplied by publisher]
	THE DOUBLE BURDEN OF CIRRHOSIS AND ACUTE PANCREATITIS: AMPLIFIED RISKS FOR NUTRITIONAL AND GASTROINTESTINAL COMPLICATIONS. Arq Gastroenterol Onwuzo CN, Odunsanya KE, Alvina F, Razeq RA, Awuah KB, Onwuzo S. PMID: 42154847 [PubMed - indexed for MEDLINE]
	ROLE OF STATINS IN CIRRHOTIC PORTAL HYPERTENSION: META-ANALYSIS OF RANDOMIZED STUDIES. Arq Gastroenterol Moreno MOA, Paz CLDSL, Rodrigues MAN, Andrade ACD, Dezan MGF, Cavalcante LN, Lyra AC. PMID: 42154843 [PubMed - indexed for MEDLINE]
	Long-Term Care in Fontan Circulation: Surveillance and Management of Fontan-Associated Liver Disease and Protein-Losing Enteropathy. Curr Cardiol Rep Jarasvaraparn C, Schooler GR, González IA, Ginde S, Mavis A. PMID: 42154163 [PubMed - indexed for MEDLINE]
	Influence of Schistosomiasis on Fibrosis Evolution After Interferon-Induced SVR in Chronic HCV Over a 12-Year Biopsy-Based Study. J Med Virol Elbasiony M, Abdel-Samiee M, Zalata K, Hassan A, Farahat A, Abdelsameea E, Shiha G, Soliman R. PMID: 42153759 [PubMed - indexed for MEDLINE]
	A Clinical-Imaging Score Reclassifies Indeterminate Diastolic Dysfunction and Predicts Posttransplant Cardiac Events in Cirrhosis. Clin Transplant Park JH, Min EK, Park J, Nam S. PMID: 42153598 [PubMed - indexed for MEDLINE]
	Prevalence and Impact of Steatotic Liver Disease in Autoimmune Liver Diseases: A Systematic Review and Meta-Analysis. Liver Int Diaz I, Ahmad S, Danpanichkul P, Souza M. PMID: 42153552 [PubMed - indexed for MEDLINE]
	Standard-Dose Ursodeoxycholic Acid Improves Biochemical Liver Function and Fibrosis in Chronic Liver Disease: Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. J Korean Med Sci Chang Y, Cho YK, Kim YS, Kim SE, Cheon GJ, Kim JH, Yang H, Kim W, Ahn SB, Yoon EL, Cheong JY, Lee JW, Kim MY, Kim HJ, Lee SH, Cho EY, Choi NR, Lee HW, Kim KM, Choe WH, Yu JM, Kim SY, Jang JY. PMID: 42153228 [PubMed - indexed for MEDLINE]
	Temporal trends in U.S. mortality from liver cirrhosis and sepsis: A 25-year retrospective analysis (1999-2023). Medicine (Baltimore) Faheem MSB, Sultan L, Zeeshan N, Sakarwala AS, Waheed A, Siddiqui SA, Hassan ST, Khan MI. PMID: 42152428 [PubMed - indexed for MEDLINE]
	Unraveling immunological heterogeneity in recalcitrant AIH-PBC/PSC overlap syndromes: from molecular crosstalk to precision therapeutics. Front Immunol Zhang Z. PMID: 42148062 [PubMed - indexed for MEDLINE]
	Currently Approved and Future Regimens for Metabolic Dysfunction-Associated Steatohepatitis. Clin Liver Dis Abreu ES, Noureddin M, Takahashi H, Schattenberg JM, Abdelmalek MF. PMID: 42142900 [PubMed - indexed for MEDLINE]
	Algorithms for Risk Stratification in Patients with Metabolic Dysfunction-Associated Steatohepatitis. Clin Liver Dis Armandi A, Bugianesi E, Loomba R, Caussy C. PMID: 42142897 [PubMed - indexed for MEDLINE]
	Noninvasive Testing for Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis. Clin Liver Dis Kalligeros M, Castera L, Tsochatzis EA, Alkhouri N. PMID: 42142896 [PubMed - indexed for MEDLINE]
	A Multicenter, Open-Label, Randomized, Non-Inferiority Trial of 8 Versus 12 Weeks of Sofosbuvir/Ravidasvir Treatment in Non-Cirrhotic Patients with Chronic Hepatitis C Virus Infection (EASE Trial). Int J Infect Dis Hassan MRA, Muhamad NA, Mohammed NS, Suan MAM, Supramaniam DNZ, Jogulu SR, Salleh MFM, Soelar SA, Rosli IA, Leman FN, Dali NSM, Maamor NH, Ngah NF, Chan HK, EASE Trial Group. PMID: 42140479 [PubMed - as supplied by publisher]
	Serum Homocysteine as an Etiology-dependent Marker of Disease Severity in Alcoholic and Viral Liver Cirrhosis: A Cross-sectional Study. Ann Afr Med Lamba M, Yadav SN, Kumar V, Atam V, Chaudhary SC, Gupta KK, Reddy DH, Patwa AK, Rungta S, Dwivedi M. PMID: 42138638 [PubMed - as supplied by publisher]
	Time of first diagnosis in liver cirrhosis: what has changed over time from etiology to stage of disease? Postgrad Med , Çelik AO, Ta, Deniz D, Murato, Nuriyev K, Genç Uluçeçen S, Rustamzade A, Da, Ya, Çavu, Çifciba, Akyüz F, Demir K, Be, Kaymako. PMID: 42138145 [PubMed - as supplied by publisher]
	The predictive role of ammonia in liver-related decompensation and mortality in patients with compensated cirrhosis: A retrospective cohort study. Can Liver J Damasceno J, Andrade L, Carvalho T, Costa RS, Costa D, Caetano AC. PMID: 42131695 [PubMed]
	Exploring the perspectives of individuals accessing outreach services to identify liver fibrosis and cirrhosis: a qualitative descriptive study. J Res Nurs Hughes M, Plant J, Baillie J. PMID: 42131495 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 38515

Seite 1 von 1926

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung